TREATMENT OF ESSENTIAL HYPERLIPIDÆMIA
Authors:
- M.F.I. FahmyMFM.F.I. Fahmy
- 1 December 1969
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 294 (7634) , 1315-1319
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Hyperlipidaemic xanthomatosis. II. Mode of inheritance in 55 families with essential hyperlipidaemia and xanthomatosis.Journal of Medical Genetics, 1968
- Cholestyramine therapy in patients homozygous for familial hypercholesterolemia (familial hypercholesterolemic xanthomatosis)Journal of Atherosclerosis Research, 1968
- Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and DisordersNew England Journal of Medicine, 1967
- The differentiation of exogenous and endogenous hyperlipemia by paper electrophoresis.Journal of Clinical Investigation, 1965
- Cholestyramine Resin Therapy for HypercholesteremiaJAMA, 1965
- IntroductionJournal of Atherosclerosis Research, 1963
- REDUCTION OF SERUM-LIPID AND URIC-ACID LEVELS BY AN ORALLY ACTIVE ANDROSTERONEThe Lancet, 1962